Achiral bis-imine in combination with CoCl₂: A remarkable effect on enantioselectivity of lipase-mediated acetylation of racemic secondary alcohol

Scholarly Works

• Basingi, S. M. M.; Matadh, S. Chemo-enzymatic Synthesis of Rivastigmine Intermediate by Locally Isolated Soil Fungus Fusarium graminearum. Current Green Chemistry 2023, 10, 160–164. doi:10.2174/2213346110666230330105603
• Xie, P.; Zhou, X.; Zheng, L. Stereoselective synthesis of a key chiral intermediate of (S)-Rivastigmine by AKR-GDH recombinant whole cells. Journal of biotechnology 2018, 289, 64–70. doi:10.1016/j.jbiotec.2018.11.016
• Braia, N.; Merabet-Khelassi, M.; Aribi-Zouioueche, L. Efficient access to both enantiomers of 3-(1-hydroxyethyl)phenol by regioselective and enantioselective CAL-B–catalyzed hydrolysis of diacetate in organic media by sodium carbonate. Chirality 2018, 30, 1312–1320. doi:10.1002/chir.23025
• Łukowska-Chojnacka, E.; Staniszewska, M.; Bondaryk, M.; Maurin, J. K.; Bretner, M. Lipase‐Catalyzed Kinetic Resolution of Novel Antifungal N‐Substituted Benzimidazole Derivatives. Chirality 2016, 28, 347–354. doi:10.1002/chir.22591
• Pramanik, A.; Roy, R.; Khan, S.; Ghatak, A.; Bhar, S. Eco-friendly synthesis of 2-aryl-1-arylmethyl-1H-benzimidazoles using alumina-sulfuric acid as a heterogeneous reusable catalyst. Tetrahedron Letters 2014, 55, 1771–1777. doi:10.1016/j.tetlet.2014.01.125
• Sethi, M. K.; Bhandya, S. R.; Kumar, A.; Maddur, N.; Shukla, R.; Mittapalli, V. J. Chemo-enzymatic synthesis of optically pure rivastigmine intermediate using alcohol dehydrogenase from baker's yeast. Journal of Molecular Catalysis B: Enzymatic 2013, 91, 87–92. doi:10.1016/j.molcatb.2013.02.010
• Bräse, S. doi:10.1002/9781118484722.ch5
• Sethi, M. K.; Bhandya, S. R.; Maddur, N.; Shukla, R.; Kumar, A.; Mittapalli, V. J. Asymmetric synthesis of an enantiomerically pure rivastigmine intermediate using ketoreductase. Tetrahedron: Asymmetry 2013, 24, 374–379. doi:10.1016/j.tetasy.2013.01.023
• Etayo, P.; Vidal-Ferran, A. Rhodium-catalysed asymmetric hydrogenation as a valuable synthetic tool for the preparation of chiral drugs. Chemical Society reviews 2013, 42, 728–754. doi:10.1039/c2cs35410a
• Yan, P.-C.; Guoliang, Z.; Xie, J.-H.; Xiangdong, Z.; Zhou, Q.-L.; Yuanqiang, L.; Shen, W.-H.; Daqing, C. Industrial Scale-Up of Enantioselective Hydrogenation for the Asymmetric Synthesis of Rivastigmine. Organic Process Research & Development 2013, 17, 307–312. doi:10.1021/op3003147
• Fuchs, M.; Koszelewski, D.; Tauber, K.; Sattler, J. H.; Banko, W.; Holzer, A. K.; Pickl, M.; Kroutil, W.; Faber, K. Improved chemoenzymatic asymmetric synthesis of (S)-Rivastigmine. Tetrahedron 2012, 68, 7691–7694. doi:10.1016/j.tet.2012.06.031
• Marcin, P.; Mahato, S. K.; Bosiak, M. J.; Krzemiński, M. P.; Zaidlewicz, M. Enantioselective reduction of ketoxime ethers with borane–oxazaborolidines and synthesis of the key intermediate leading to (S)-rivastigmine. Tetrahedron: Asymmetry 2012, 23, 716–721. doi:10.1016/j.tetasy.2012.05.008
• Etayo, P.; Núñez-Rico, J. L.; Fernández-Pérez, H.; Vidal-Ferran, A. Enantioselective access to chiral drugs by using asymmetric hydrogenation catalyzed by Rh(P-OP) complexes. Chemistry (Weinheim an der Bergstrasse, Germany) 2011, 17, 13978–13982. doi:10.1002/chem.201103014
• Arava, V. R.; Gorentla, L.; Dubey, P. K. A Simple and Highly Efficient Enantioselective Synthesis of (S)-Rivastigmine. International Journal of Organic Chemistry 2011, 01, 26–32. doi:10.4236/ijoc.2011.12005

Explore citations to this article at